Form 4: Baskett Forest Reports Beneficial Ownership Changes in MBX Biosciences Following IPO

Following MBX Biosciences' IPO, Baskett Forest, a manager at NEA 17 GP, LLC, reported changes in beneficial ownership due to the conversion of preferred stock into common stock and the purchase of additional shares.

Summary

• Baskett Forest, a reporting person related to NEA 17, filed a Form 4 detailing changes in beneficial ownership of MBX Biosciences, Inc. common stock on September 16, 2024.
• The changes are due to the conversion of Series A and Series B Convertible Preferred Stock into common stock immediately prior to the closing of MBX Biosciences' IPO.
• Forest also purchased 500,000 shares of common stock at $16 per share.
• Following these transactions, the total amount of common stock beneficially owned indirectly is 3,614,486 shares.

Sentiment

Score: 7

Explanation: The document reflects standard transactions related to an IPO, with a neutral sentiment. The purchase of shares at $16 indicates confidence.

Industry Context

Form 4 filings are standard practice following significant transactions, such as an IPO, to disclose changes in ownership by insiders and major shareholders.

Stakeholder Impact

• The conversion of preferred stock to common stock impacts the ownership structure of the company.
• The purchase of shares by a significant beneficial owner may signal confidence in the company's future prospects.

Key Dates